PubAg

Main content area

Effects of retinol binding protein-4 on vascular endothelial cells

Author:
Takebayashi, Kohzo, Sohma, Ryouichi, Aso, Yoshimasa, Inukai, Toshihiko
Source:
Biochemical and biophysical research communications 2011 v.408 no.1 pp. 58-64
ISSN:
0006-291X
Subject:
calcium, cattle, chelating agents, endothelial nitric oxide synthase, human umbilical vein endothelial cells, insulin, mitogen-activated protein kinase, nitric oxide, phosphatidylinositol 3-kinase, phosphorylation, rats, retinol-binding protein, secretion, small interfering RNA, vasodilation, vitamin A
Abstract:
The study was designed to investigate the effect of retinol binding protein (RBP)-4 on the phosphatidylinositol 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) pathways, which mediate the effects of insulin in vascular endothelial cells. The effects of RBP4 on nitric oxide (NO) and insulin-stimulated endothelin-1 (ET-1) secretion and on phosphorylation (p) of Akt, endothelial NO synthetase (eNOS), and extracellular signal-regulated kinase (ERK)1/2 were investigated in bovine vascular aortic endothelial cells (BAECs). RBP4 showed an acute vasodilatatory effect on aortic rings of rats within a few minutes. In BAECs, RBP4-treatment for 5min significantly increased NO production, but inhibited insulin-stimulated ET-1 secretion. RBP4-induced NO production was not inhibited by tetraacetoxymethylester (BAPTA-AM), an intracellular calcium chelator, but was completely abolished by wortmannin, a PI3K inhibitor. RBP4 significantly increased p-Akt and p-eNOS production, and significantly inhibited p-ERK1/2 production. Triciribine, an Akt inhibitor, and wortmannin significantly inhibited RBP4-induced p-Akt and p-eNOS production. Inhibition of Akt1 by small interfering RNA decreased p-eNOS production enhanced by RBP4 in human umbilical vein endothelial cells. In conclusion, RBP4 has a robust acute effect of enhancement of NO production via stimulation of part of the PI3K/Akt/eNOS pathway and inhibition of ERK1/2 phosphorylation and insulin-induced ET-1 secretion, probably in the MAPK pathway, which results in vasodilatation.
Agid:
893851